Stifel Nicolaus Reaffirms Their Buy Rating on Disc Medicine (IRON)
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Disc Medicine (IRON – Research Report), with a ...
Stifel Nicolaus Sticks to Their Buy Rating for Xenon (XENE)
In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Xenon (XENE – Research Report), with a price target of ...
Stifel raises SiteOne stock rating, trims price target to $140
Stifel analysts adjusted their stance on SiteOne Landscape Supply (NYSE: NYSE:SITE), upgrading the stock from 'Hold' to 'Buy' while slightly reducing the price target to $140 from $145. The upgrade ...
Tesla's stock falls again, and this analyst says why it's an Elon Musk problem
Musk's political involvement and resulting reduced popularity has already hit sales in Europe, and appears to be hurting sales in China. In Tesla's fourth-quarter earnings report, the company posted ...
Stifel maintains Buy rating on Freshpet stock, target at $165
Stifel analysts reiterated their Buy rating on Freshpet shares (NASDAQ:FRPT), maintaining a price target of $165.00. According to InvestingPro data, analyst consensus remains strongly bullish with ...